Literature DB >> 19345431

The importance of considering alternative or combination strategies for lowering LDL-C.

Kwang Kon Koh, Michael J Quon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19345431      PMCID： PMC2758221          DOI： 10.1016/j.ijcard.2009.03.035

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  24 in total

1.  Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Wook-Jin Chung; Jeong Yeal Ahn; Yiel-Hea Seo; In Suck Choi; Eak Kyun Shin
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

2.  Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.

Authors:  Roberto Corti; Valentin Fuster; Zahi A Fayad; Stephen G Worthley; Gerard Helft; William F Chaplin; Jörg Muntwyler; Juan F Viles-Gonzalez; Jesse Weinberger; Donald A Smith; Gabor Mizsei; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

3.  Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Jeong Yeal Ahn; Dong Kyu Jin; Hyung Sik Kim; Dae Sung Kim; Eak Kyun Shin
Journal:  Hypertension       Date:  2005-05-09       Impact factor: 10.190

4.  Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function.

Authors:  Martin Rodriguez-Porcel; Lilach O Lerman; Joerg Herrmann; Tatsuya Sawamura; Claudio Napoli; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-27       Impact factor: 8.311

5.  Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Wook-Jin Chung; Jeong Yeal Ahn; Yiel-Hea Seo; Moon Ho Kang; Tae Hoon Ahn; In Suck Choi; Eak Kyun Shin
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

6.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

7.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

8.  Low serum total cholesterol concentrations and mortality in middle aged British men.

Authors:  G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  BMJ       Date:  1995-08-12

9.  Report of the Conference on Low Blood Cholesterol: Mortality Associations.

Authors:  D Jacobs; H Blackburn; M Higgins; D Reed; H Iso; G McMillan; J Neaton; J Nelson; J Potter; B Rifkind
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

10.  Role of smoking in the U-shaped relation of cholesterol to mortality in men. The Framingham Study.

Authors:  R B D'Agostino; A J Belanger; W B Kannel; M Higgins
Journal:  Am J Epidemiol       Date:  1995-05-01       Impact factor: 4.897
View more
  1 in total

Review 1.  Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction.

Authors:  Kwang Kon Koh; Seung Hwan Han; Pyung Chun Oh; Eak Kyun Shin; Michael J Quon
Journal:  Atherosclerosis       Date:  2009-09-12       Impact factor: 5.162
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.